Open Beta
MetriLume

US marketsTMDX

SEC-sourced researchBeta

TMDX

TransMedics Group, Inc.

Company comparison ↗

Data passport

CIK
0001756262
Exchange
Nasdaq
Business activity
— · SIC 3845
Financial inputs
6/6
Filing date
Sep 29, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 241,623,000.0000 USD; December 2024: 441,540,000.0000 USD; December 2025: 605,494,000.0000 USD605.5M USD0 USD0December 2023December 2024December 2025
TMDX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023241,623,000.0000Feb 24, 2026
December 2024441,540,000.0000Feb 24, 2026
December 2025605,494,000.0000Feb 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025605,494,000.0000190,291,000.0000192,840,000.00001,068,373,000.0000595,273,000.0000Feb 24, 2026
December 2024441,540,000.000035,464,000.000048,803,000.0000804,076,000.0000575,473,000.0000Feb 24, 2026
December 2023241,623,000.0000-25,028,000.0000-13,028,000.0000——Feb 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$605.49MDecember 2025Feb 24, 202610-K
Previous period revenueRevenues$441.54MDecember 2024Feb 24, 202610-K
Net incomeNetIncomeLoss$190.29MDecember 2025Feb 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$192.84MDecember 2025Feb 24, 202610-K
Total assetsAssets$1.07BDecember 2025Feb 24, 202610-K
Total liabilitiesLiabilities$595.27MDecember 2025Feb 24, 202610-K

New filings

Explore methodology ↗